NCT07304908

Brief Summary

Large language models (LLMs) show promise in medicine, but concerns about their accuracy, coherence, transparency, and ethics remain. To date, public perceptions on using LLMs in medicine and whether they play a role in the acceptability of health care applications of LLMs are not yet fully understood. This study aims to investigate public perceptions on using LLMs in medicine and if interventions for perceptions affect the acceptability of health care applications of LLMs.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,000

participants targeted

Target at P75+ for not_applicable

Timeline
6mo left

Started Nov 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress50%
Nov 2025Dec 2026

Study Start

First participant enrolled

November 25, 2025

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

December 1, 2025

Completed
25 days until next milestone

First Posted

Study publicly available on registry

December 26, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

December 26, 2025

Status Verified

December 1, 2025

Enrollment Period

11 months

First QC Date

December 1, 2025

Last Update Submit

December 11, 2025

Conditions

Keywords

Large language modelArtificial intelligencePerception-based interventionsPublic acceptance

Outcome Measures

Primary Outcomes (1)

  • Number of participants who will change their attitudes towards medical applications of large language models

    Public acceptance of applying large language models to medicine will be categorized into yes, not sure, and no, which will be collected before perception-based interventions and after interventions.

    Through study completion, an average of 1 year

Study Arms (4)

Perceived benefits of large language models in medicine

EXPERIMENTAL

Participants were asked to read "In April 2023, Massachusetts General Hospital launched a pilot program utilizing medical LLMs to assist with emergency department triage and initial diagnosis and observed a reduction in patient wait times and an improvement in clinical efficiency."

Other: Perception-based interventions

Perceived racial bias in large language models in medicine

EXPERIMENTAL

Participants were asked to read "In November 2022, a research team from the University of California, San Francisco found that cutting-edge medical LLMs exhibited racial bias when recommending treatment plans."

Other: Perception-based interventions

Perceived ethical conflicts in large language models in medicine

EXPERIMENTAL

Participants were required to read "In February 2023, a major European hospital network inadvertently leaked partially anonymized but still sensitive patient data during the testing of medical LLMs due to a system configuration error. Although no direct patient harm occurred, this increased public concerns regarding data privacy and security and compelled relevant institutions to conduct urgent reviews of their data protection measures."

Other: Perception-based interventions

Control

NO INTERVENTION

No intervention

Interventions

Participants allocated to the intervention group received perception-based interventions. Interventions for Groups 1-3 were perceived benefits of LLMs in medicine, perceived racial bias in LLMs in medicine, and perceived ethical conflicts in LLMs in medicine, respectively.

Perceived benefits of large language models in medicinePerceived ethical conflicts in large language models in medicinePerceived racial bias in large language models in medicine

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥18 years
  • Capable of completing an online survey
  • Agree to sign an informed consent form

You may not qualify if:

  • Unable to answer questions or communicate
  • Not willing to participate in this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jue Liu

Beijing, Beijing Municipality, 100191, China

Location

MeSH Terms

Conditions

Patient Acceptance of Health Care

Condition Hierarchy (Ancestors)

Treatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Jue Liu

    Peking University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof.

Study Record Dates

First Submitted

December 1, 2025

First Posted

December 26, 2025

Study Start

November 25, 2025

Primary Completion (Estimated)

October 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

December 26, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations